What does voyager therapeutics do? About Voyager TherapeuticsVoyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for serious neurological diseases.What is variablevoyager therapeutics mailing address? Voyager Therapeutics' mailing address is 75 SIDNEY STREET, CAMBRIDGE MA, 02139. The company can be reached via phone at (857) 259-5340 or via email at [email protected]. How do i contact voyager investor relations? Investor Relations. Voyager Digital Ltd. 33 Irving Place, Suite 3060. New York, NY 10003. United States. Telephone: +1 (212) 547-8807. Email: [email protected]. Should you hold voyager therapeutics vygr stock? The consensus among Wall Street research analysts is that investors should "hold" Voyager Therapeutics stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VYGR, but not buy additional shares or sell existing shares.
Business Overview "Voyager Therapeutics Inc" of Cambridge, MA 02139 operates primarily in SIC Code 8731 - Commercial Physical and Biological Research and NAICS Code 541714 - Research and Development in Biotechnology (except Nanobiotechnology).Voyager Therapeutics Inc is a small-sized business with medium revenue, that is established in its ...
857-259-5340 Phone Number 857-259-5340 Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS).
1Nonnenmacher, et al. “RNA-driven Evolution of AAV Capsid Libraries Identifies Variants with High Transduction Efficiency in Non-Human Primate Central Nervous System.” ASGCT 2021. Contact Us Voyager Therapeutics 75 Sidney St. Cambridge, MA ...
You may contact a specific member of the Voyager Therapeutics Board of Directors to provide comments, to report concerns, or to ask a question, at the following address: Corporate Secretary. Attn: [Name of Member of the Board] Voyager Therapeutics, Inc. 75 Sidney Street. Cambridge, MA 02139. United States.
The Investor Relations website contains information about Voyager Therapeutics Inc.'s business for stockholders, potential investors, and financial analysts.
Voyager Therapeutics, Inc. is a Delaware Corporation filed On June 19, 2013. The company's File Number is listed as 5353612. The Registered Agent on file for this company is The Corporation Trust Company and is located at Corporation Trust Center 1209 Orange St, Wilmington, DE 19801.
About Us It’s Personal. Diseases of the brain affect more than 200 million people, manifesting at all ages and stages of life, and many of us know someone with a serious neurological disorder. 4 At Voyager, we are working to unlock the enormous promise gene therapy has for treating these and other serious diseases.
Company profile page for Voyager Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information
857 259-5340 Voyager Therapeutics Inc. 75 Sidney Street. Cambridge, Massachusetts 02139. Phone 1 857 259-5340. Industry Biotechnology. Sector Health Care/Life Sciences.
Voyager Therapeutics, Inc. uses 4 email formats. The most common Voyager Therapeutics, Inc. email format is first_initial last (ex. [email protected] ) being used 83.5% of the time. Other common formats are first (ex. [email protected] ) and first_initial '-' last (ex. [email protected] ) .
Prior to joining Vectiv, Dr. Khwaja served as Chief Medical Officer and Head of Research and Development at Voyager Therapeutics, a biotechnology company focused on severe neurological diseases. Previously, he was the Global Head of Rare Diseases and Neuroscience Translational Medicine at Roche, where he worked for over eight years.
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trial for the treatment of Parkinson's disease.
Voyager Therapeutics has 13 current employee profiles, including Scientific Founder & SAB member Mark Kay. Voyager Therapeutics has 2 board members and advisors, including Perry Karsen . Contacts
Voyager Therapeutics has 185 employees at their 1 location and $171.13 M in annual revenue in FY 2020. See insights on Voyager Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.